Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Rev. bras. farmacogn ; 25(5): 513-521, Sept.-Oct. 2015. tab, graf
Article in English | LILACS | ID: lil-765075

ABSTRACT

ABSTRACTChlorogenic and caffeic acids are bioactive phenolic compounds present in Cecropia glaziovii Snethl., Urticaceae, products that have been used as analytical markers. This paper reports a chemometric study aimed at improving chromatographic performance for quantification of these markers by RP-HPLC. The organic to aqueous content ratio, the acid content of the mobile phase, and the elution method were analyzed using a Response Surface Methodology IV-Optimal design. The resolution between peaks, retention time, tailing and retention factors, number of theoretical plates and peak widths were evaluated. The optimized conditions were mathematically determined as (A) trifluoroacetic acid 0.05% (v/v), (B) 12% (v/v) acetonitrile and (C) increasing gradient. The method was considered specific, fast, precise, reliable and linear in the ranges of 1.0–200.0 and 2.5–100.0 µg/ml for the chlorogenic and caffeic acids, respectively. The adequate conditions to separate and quantify both phenolic acids in C. glaziovii products were demonstrated. Satisfactory resolution was achieved when compared to a previously published chromatographic method which is unable to separate the chlorogenic acid and an interfering compound presented under certain extractive conditions, demonstrating the importance of systematic studies, specifically when analyzing complex plant matrices.

2.
Rev. bras. farmacogn ; 23(1): 160-168, Jan.-Feb. 2013. ilus, tab
Article in English | LILACS | ID: lil-666172

ABSTRACT

Cecropia glaziovi Snethl., Urticaceae, is commonly used in South America and is one of the species included in the Brazilian Medicinal Plants Research Program. Pharmacological studies have led to reports of the potential of C. glaziovi as a hypotensive, antiasthmatic and anxiolytic agent. The strict requirements regarding the quality, safety and effectiveness of phytopharmaceutical products represent an enormous challenge in the search for products with a high level of uniformity, reproducibility and stability. The incorporation of dry extracts into multiparticulate dosage forms, such as pellets produced by extrusion/spheronization technology, is a suitable alternative to overcome the lack of technological properties of dry extracts, since they are associated with low flowability and high hygroscopicity. In this study, an optimized dry extract (ODE) of C. glaziovi was incorporated into pellets seeking to decrease the moisture sorption and increase the stability, safety and percentage of the extract in the final product. Pellets containing around 50% of ODE were considered the most technologically viable, offering a narrow particle size distribution, significant improvement in the flowability and compressibility properties, and decrease in the moisture compared with the ODE. In conclusion, pellets containing a high dose of the C. glaviovi extract were successfully prepared, achieving degrees of quality, physical stability and feasibility compatible with the desirable characteristics of a phytopharmaceutical.

SELECTION OF CITATIONS
SEARCH DETAIL